Hany M Fayed

10PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsPreventative health careEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 24, 2026
Ertugliflozin Mitigates Cisplatin‑Induced Peripheral Neuropathy in Rats via Nrf2/HO‑1 and p38 MAPK/NF-κB Pathways.

|Oct 10, 2026
Vildagliptin attenuates thioacetamide-induced hepatic fibrosis in rats: associations with AMPK/SIRT1/Nrf2 and STAT3/TGF-β1 signaling.

|Aug 13, 2026
Remogliflozin attenuates thioacetamide-induced nephrotoxicity: association with Nrf2/HO-1, SIRT1/AMPK, and TLR4/NF-κB pathway modulation.

|Jul 09, 2026
Protective Role of Linagliptin in Cisplatin-Mediated Liver Injury: Involvement of STAT3 and AMPK/SIRT1/PGC-1alpha Mitochondrial Energy Sensing Networks.

|Jan 07, 2026
Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats.

Hossein M Elbadawy, Mohannad A Almikhlafi, Mohammed H Alsubhi

|Jan 31, 2024
Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway.

Marawan A Elbaset, Bassim M S A Mohamed, Passant E Moustafa

Pageof 2

Frequent Collaborators

5 joint publications

Marawan Abd Elbaset Mohamed

4 joint publications

Tuba Esatbeyoglu

3 joint publications

Rehab F Abdel-Rahman

3 joint publications

Sahar S M Abdelrahman